CREDIT SUISSE AG/ - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 16 filers reported holding BENITEC BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q4 2020$47,000
-52.0%
15,5780.0%0.00%
Q3 2020$98,00015,5780.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 796,837$296,0001.76%
Altium Capital Management LP 658,796$245,0000.09%
CVI Holdings, LLC 1,289,128$479,0000.04%
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$286,0000.01%
ARMISTICE CAPITAL, LLC 1,555,039$578,0000.01%
FRANKLIN RESOURCES INC 10,000,000$3,717,0000.00%
WealthTrust Axiom LLC 12,950$4,0000.00%
CANTOR FITZGERALD, L. P. 133,805$50,0000.00%
Walleye Capital LLC 190,678$71,0000.00%
UBS Group AG 28,683$11,0000.00%
View complete list of BENITEC BIOPHARMA INC shareholders